Drug intelligence / Profile preview

Kelapher

Development stage
Unknown
Lead developer
Meditrina Pharmaceuticals
Modality
Recombinant Proteins and Enzymes, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Topical
01

Overview

Kelapher is a topical medical device developed by the Greek pharmaceutical company MEDITRINA for the treatment of skin discolorations (dyschromias). The active ingredient is Lactoferrin LT (Lipid Technology), which is a liposomal formulation of lactoferrin, a multifunctional glycoprotein. Kelapher works primarily by chelating free iron in tissues, which reduces hemosiderin-induced pigmentation commonly associated with hematomas, ecchymoses, and postoperative bruising. Beyond its iron-chelating properties, lactoferrin provides antioxidant, anti-inflammatory, antibacterial, and wound-healing benefits. The product is available as a cream and in ampoule form for local application on lesions caused by vascular procedures, varicose ulcers, scars, burns, and post-laser treatments.

Brand names
KelapherKelapher 2.BKelapher2.BKelapher-2.BKelapher Cream
Other names
Lactoferrin LTLiposomal lactoferrin

Beyond the preview

Go deeper on Kelapher.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kelapher.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call